Large Cap High Growth Potential

Results

17

2 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

17 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	VACN	CHF 633.20	5.2%	122.0%	CHF 19.0b	CHF 699.94	91.4	24.8%	1.1%	Capital Goods
	STMN	CHF 102.90	3.0%	1.9%	CHF 16.4b	CHF 110.33	46.0	15.7%	1.0%	Healthcare
	BEAN	CHF 848.00	1.0%	-8.6%	CHF 10.4b	CHF 1,018.90	50.8	13.9%	1.2%	Capital Goods
	GALD	CHF 181.35	3.2%	39.4%	CHF 42.3b	CHF 192.09	60.7	22.9%	0.2%	Pharmaceuticals & Biotech
	HBAN	CHF 217.00	0.09%	5.8%	CHF 21.5b	CHF 231.36	39.4	29.6%	3.5%	Insurance
	HOLN New	CHF 70.82	-3.4%	4.0%	CHF 39.2b	CHF 82.20	99.7	26.4%	2.4%	Materials
	SDZ New	CHF 72.78	10.7%	53.9%	CHF 31.5b	CHF 71.00	60.4	22.8%	1.1%	Pharmaceuticals & Biotech
	NOVN	CHF 125.98	-0.5%	33.9%	CHF 239.5b	CHF 124.40	23.2	11.0%	2.9%	Pharmaceuticals & Biotech
	SOON	CHF 235.60	7.1%	4.8%	CHF 14.0b	CHF 223.72	26.1	10.4%	2.0%	Healthcare
	UHR	CHF 189.05	4.9%	33.3%	CHF 9.8b	CHF 169.54	1092.2	40.8%	2.4%	Consumer Durables
	CFR	CHF 195.45	2.4%	48.2%	CHF 115.0b	CHF 210.42	35.5	15.5%	1.7%	Consumer Durables
	LONN	CHF 572.20	1.8%	5.1%	CHF 40.0b	CHF 681.13	37.0	17.3%	0.9%	Pharmaceuticals & Biotech
	NESN	CHF 81.21	0.2%	12.6%	CHF 208.9b	CHF 88.86	28.1	12.7%	3.8%	Food, Beverage & Tobacco
	SGSN	CHF 97.04	1.3%	18.6%	CHF 19.2b	CHF 101.63	28.9	10.0%	3.3%	Commercial Services
	ABBN	CHF 81.76	2.8%	52.0%	CHF 148.4b	CHF 80.79	36.9	7.6%	1.1%	Capital Goods
	ALC	CHF 57.34	3.5%	-17.0%	CHF 28.0b	CHF 76.29	42.3	18.3%	0.5%	Healthcare
	PGHN	CHF 732.40	9.0%	-35.8%	CHF 18.9b	CHF 825.00	15.0	6.4%	6.3%	Diversified Financials

Page 1 of 1